Response to Harms et al
- PMID: 35500639
- DOI: 10.1016/j.jid.2022.04.012
Response to Harms et al
Comment on
- 
  
  Comment on "An Epidemiologic Analysis of Melanoma Overdiagnosis in the United States, 1975-2017".J Invest Dermatol. 2022 Nov;142(11):3120-3122. doi: 10.1016/j.jid.2022.03.028. J Invest Dermatol. 2022. PMID: 36273837 No abstract available.
Publication types
Grants and funding
LinkOut - more resources
- Full Text Sources
 
        